Vascular Therapies Stock
Vascular Therapies is a biopharma company that aims to improve vascular surgery outcomes in patients with kidney and vascular diseases.
Sign up today and learn more about Vascular Therapies Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Vascular Therapies Stock
Vascular Therapies (VT) is a biopharmaceutical company committed to the development and commercialization of innovative new treatments to address major unmet clinical needs of patients requiring a vascular access to support hemodialysis. Our lead product candidate, containing sirolimus, has received orphan drug designations in the U.S. and E.U. for the dialysis vascular access indications. The company was founded in 2001 and headquartered in Cresskill, New Jersey.
Founder, Chief Scientific Officer & Board Member